Zimmer Biomet Holdings, Inc. has a strong presence in the musculoskeletal healthcare business, offering a diverse product range for orthopedic and dental solutions. The stock has been performing steadily with promising fundamentals that appeal to investors and analysts alike. With a focus on innovation, Zimmer Biomet continues to expand its market presence globally.
Zimmer Biomet shows a moderate to strong financial performance across key metrics. Below are the ratings for fundamental financial categories:
| Category | Score | Score Bar |
|---|---|---|
| Discounted Cash Flow | 5 | |
| Return on Equity | 4 | |
| Return on Assets | 4 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 3 |
The historical ratings indicate consistency over time, with stable scores in major categories:
| Date | Overall | DCF | ROE | ROA | Debt to Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-09-05 | 3 | 5 | 4 | 4 | 1 | 2 | 3 |
| N/A | 0 | 5 | 4 | 4 | 1 | 2 | 3 |
Zimmer Biomet shows promising price targets based on analyst forecasts:
| High | Low | Median | Consensus |
|---|---|---|---|
| $115 | $96 | $101 | $104.4 |
The sentiment among analysts remains positive, predominantly favoring buy recommendations:
| Recommendation | Count | Distribution |
|---|---|---|
| Buy | 20 | |
| Hold | 18 | |
| Sell | 3 |
Zimmer Biomet Holdings, Inc. presents a stable investment with a reasonably strong financial backbone and favorable analyst ratings. Despite a challenging market environment, the company's consistent product innovation and strategic market expansion offer growth potential. Investors might find the stock appealing given its strong fundamentals and positive industry outlook. However, as with any investment, consideration of risks like regulatory changes and market volatility is essential. Overall, Zimmer Biomet warrants attention for those seeking exposure in the healthcare sector.